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ABSTRACT 
 
A  one-pot  condensation  of  isotryptamines  and  aldehydes  that  affords  enantiomerically  enriched  4-substituted 
tetrahydro-γ-carbolines is reported.  The reaction is induced by a chiral thiourea/benzoic acid dual catalyst system. 
Purification of the N-Boc-protected products by trituration or crystallization provides the optically pure tetrahydro-γ-
carboline derivatives in a scalable and highly practical procedure. 
  Natural  and  synthetic  compounds  containing  the 
tetrahydro-β-carboline  heterocyclic  framework  are 
endowed  with  an  extraordinary  range  of  important 
biological  activities.
1 The  closely  related  tetrahydro-γ-
carboline  framework  is  unknown  in  natural  product 
structures,  but  also  holds  considerable  potential  as  a 
template  for  drug  discovery.
2   In  contrast  to  the  rich 
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assortment of known synthetic routes to chiral tetrahydro-
β-carboline  derivatives,
  3 , 4  few  methods  have  been 
indentified for the direct preparation of optically enriched 
tetrahydro-γ-carbolines.  Reported  strategies  to  the  latter 
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5 
diastereoselective  cyclization  of  chiral,  substituted 
precursors,
6  and  Pd-catalyzed  enantioselective 
intramolecular  allylic  alkylation.
7 We  describe  here  a 
straightforward  and  direct  route  to  enantiomerically 
enriched 4-substituted tetrahydro-γ-carbolines through an 
enantioselective, catalytic “iso-Pictet￿Spengler reaction”, 
the  one-pot  condensation/cyclization  of  2-substituted 
indolylethylamines  (isotryptamines)  and  aldehydes 
(Scheme 1).
8 
 
Scheme  1.  Synthesis  of  tetrahydro-β-carbolines  and  proposed 
route to tetrahydro-γ-carbolines co-catalyzed by chiral thioureas 
and BzOH 
 
 
  Our approach drew directly on the recent discovery that 
the combination of chiral thioureas and carboxylic acid 
derivatives  can  serve  as  a  highly  effective  co-catalyst 
system  for  enantioselective  one-pot  Pictet￿Spengler 
reactions  of  tryptamines  and  aldehydes  (Scheme  1).
  4a   
Under the conditions optimized for that reaction (thiourea 
1/benzoic acid, 20 mol%), the model iso-Pictet–Spengler 
reaction  between  unsubstituted  isotryptamine  2a  and  4-
chlorobenzaldehyde 3m was found to proceed efficiently 
to  the  desired  tetrahydro-γ-carboline  4am  (>98% 
conversion within 1 h), and with 66% ee (entry 1, Table 
1).
 Chiral thiourea 5a, which was identified previously as 
an effective catalyst for Strecker reactions,
9 was found to 
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be  more  effective,  affording  4am  in  79%  ee  (entry  2). 
Substantially  higher  enantioselectivity  was  observed  in 
the reaction of 2a and isobutyraldehyde 3n (89% ee). In 
all  cases,  it  was  found  that  the  thiourea  needed  to  be 
present at a concentration equal to or greater than that of 
the achiral carboxylic acid in order to prevent diminished 
enantioselectivities  due  to  an  acid-catalyzed  racemic 
background reaction.
10 This proved to a particular concern 
with  iso-Pictet–Spengler  reactions  with  aliphatic 
aldehydes,  which  may  contain  detectable  levels  of  the 
corresponding  aliphatic  acids  as  received  from 
commercial  suppliers.    Accordingly,  for  some  aliphatic 
substrates,  it  was  found  that  reducing  the  loading  of 
BzOH led to measurable improvements in product ee (e.g., 
91%  ee  vs.  89%  ee  for  4an,  entries  3  and  4).  Further 
optimization  of  the  thiourea  catalyst  structure  revealed 
that the highly sterically demanding derivative 5b bearing 
the  3,5-dimethylbenzhydryl  group  on  the  amide 
component  afforded  tetrahydro-γ-carboline  4an  in  97% 
yield and 95% ee (entry 5).   
 
Table  1.  Optimization  of  the  Enantioselective  Iso-
Pictet￿Spengler Reaction 
 
a  Isolated  yield  after  purification;  >98%  conversion  in  all  cases. 
b 
Determined  by  HPLC  analysis  of  the  N-Boc  derivative. 
c  nd  =  not 
determined. 
 
The  thiourea/benzoic  acid  co-catalyzed  iso-
Pictet￿Spengler  reaction  was  applied  successfully  to  a 
variety  of  isotryptamine-aldehyde  combinations,  as 
illustrated  in  Table  2.  In  particular,  high 
enantioselectivities  were  obtained  in  the  cyclization  of  
sterically demanding aliphatic or aromatic aldehydes with 
both  electron-rich  and  electron  deficient  isotryptamine 
derivatives using thiourea 5b (entries 2-18). In contrast, 
aldehydes lacking branching at the α position proved less 
effective as substrates (entry 1, and discussion below).    
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Pictet−Spengler reaction of 2a with 3n to 30% conversion in 0.5 h. 
 entry aldehyde  thiourea 
BzOH 
(mol %)  product 
yield 
(%)
a 
ee 
(%)
b 
1  3m  1  20  4am  nd
c  66 
2  3m  5a  20  4am  95  79 
3  3n  5a  20  4an  98  89 
4  3n  5a  10  4an  97  91 
5  3n  5b  10  4an  97  95  
Table 2. Substrate Scope of the Thiourea-/BzOH-Co-Catalyzed 
Enantioselective Iso-Pictet￿Spengler Reaction Catalyzed by 5b 
 
entry 
isotryptamine 
(X) 
aldehyde 
(R) 
BzOH 
(mol %) 
time 
(h)  product  yield 
(%)
a 
ee 
(%)
b 
1  2a (H)  3o (i-Bu)  20  1  4ao  96  79 
2  2a  3p (c-Hex)  20  1  4ap  96  91 
3  2a  3q (CH(Et)2)  20  3  4aq  97  95 
4  2a  3r (t-Bu)  20  7 d  4ar  83
c  87 
5  2a 
3s  
(o-MeC6H4)  20  1  4as  99  92 
6  2a  3t (1-naph)  20  2  4at  96  86 
7  2b (5-F)  3n  10  1  4bn  98  94 
8  2c (6-F)  3n  10  1  4cn  97  94 
9  2d (5-MeO)  3n  10  1  4dn  96  94 
10  2e (6-MeO)  3n  10  1  4en  94  94 
11  2f (5-Me)  3n  10  1  4fn  95  95 
12  2g (5-vinyl)  3n  10  1  4gn  97  95 
13  2d  3p  20  1  4dp  98  91 
14  2f  3p  20  1  4fp  93  93 
15  2b  3p  20  1  4bp  99  90 
16  2c  3q  20  5  4cq  96  93 
17  2b  3s  20  2  4bs  96  88 
18  2d   3s  20  1  4ds  93  91 
a Isolated yield after purification. 
b Determined by HPLC analysis of 
the N-Boc derivative. 
c 90% conversion. 
 
Any variability in the enantioselectivity of the thiourea-
catalyzed  iso-Pictet–Spengler  reaction  proved  to  be  of 
only  minor  consequence,  however,  thanks  to  the 
identification of a remarkably straightforward protocol for 
upgrading the ee of the tetrahydro-γ-carboline products.  
As  illustrated  in  Table  3,  the  crude  products  of  the 
cyclization  reaction  were  subjected  to  reaction  with 
Boc2O  at  ambient  temperature,  and  the  enantiomeric 
composition of the resulting N-Boc tetrahydro-γ-carboline 
6 could be upgraded to >99% ee in nearly all cases by 
direct crystallization or trituration.
 11 This allowed use of 
reduced  loadings  of  the  less  enantioselective  but 
commercially available catalyst 5a,
12 and extension of the 
method  to  substrates  that  undergo  reaction  with  only 
moderate intrinsic enantioselectivity, such as unhindered 
aliphatic  (entries  1-2)  and  aromatic  (entries  6-9) 
aldehydes. This one-pot synthetic procedure for preparing 
enantiopure  N-Boc  tetrahydro-γ-carboline  derivatives 
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required  no  chromatographic  purification  steps  and 
should be readily adaptable to preparative scale.    
 
 
Table 3. One-Pot Method for the Preparation of Optically Pure 
Tetrahydro-γ-Carboline Derivatives 
 
entry     isotryptamine 
aldehyde 
(R) 
time 
(h)  product 
ee        
(%)
a 
yield 
(%)
b 
1  2a   3u (n-pent)  1  6au  >99 (61)  45 
2  2a  3o (i-Bu)
c  1  6ao  >99 (74)  55 
3  2a  3n (i-Pr)  1  6an  >99 (88)  81 
4  2a  3p (c-Hex)
c  1  6ap  99 (91)  65 
5  2a  3q (CH(Et)2)  5  6aq  >99 (90)  79 
6  2a  3v (C6H5)  1  6av  >99 (70)  52 
7  2a  3w (p-FC6H4)  1  6aw  >99 (74)  64 
8  2a  3m (p-ClC6H4)  1  6am  >99 (76)  63 
9  2a  3x (p-BrC6H4)  1  6ax  >99 (75)  56 
10  2a  3s (o-MeC6H4  2  6as  >99 (86)  77 
11  2b  3n  1  6bn  >99 (88)  78 
12  2c  3n  1  6cn  >99 (89)  77 
13  2d  3n  1  6dn  98 (85)  78 
14  2g  3n
 c  1  6gn  >99 (92)  67 
15  2d  3p  1  6dp  >99 (92)  81 
16  2b  3s  2  6bs  >99 (79)  66 
17  2d  3s  2  6ds  99 (87)  74 
a Determined by HPLC analysis. Numbers in parentheses correspond 
to the ee of 6 before trituration or recrystallization. For details on the 
trituration  or  recrystallization  procedures,  see  the  Supporting 
Information. 
b Isolated yield of product with upgraded ee. 
 c 20 mol % 5a 
used. 
 
Ketone substrates were also applied successfully to the 
iso-Pictet￿Spengler protocol. As depicted in Scheme 2, 
the  ketoimine  generated  in situ  from  2a  and  ketone  7 
underwent enantioselective cyclization in the presence of 
5a and benzoic acid to afford the tetrahydro-γ-carboline 8 
in  95%  yield  and  76%  ee.  After  N-Boc  protection  and 
trituration, 9 was isolated in 98% ee. 
 
Scheme 2. Enantioselective Iso-Pictet￿Spengler Reaction of 2a 
and Ketone 7 
  
 Tetrahydro-β-carboline  derivatives  are  the  common 
biosynthetic  precursors  of  the  monoterpenoid  indole 
alkaloid  natural  product  family,  which  includes 
rearranged  examples  such  as  morphine.
13 We  explored 
whether  the  tetrahydro-γ-carboline  framework  might 
undergo analogous transformations into structurally and 
stereochemically complex alkaloid scaffolds. In particular, 
we  targeted  the  synthesis  of  a  spirocyclic  oxindole,  a 
frequently observed structural motif in biologically active 
compounds.
14,15 Through  the  treatment  of  tetrahydro-γ-
carboline    6ao  with  NBS  under  acidic  conditions, 
optically  active  spiro  indoxyl  10  was  isolated  in  48% 
yield (Scheme 3).
16 Oxidative rearrangement product 10 
features contiguous nitrogen-bearing stereogenic centers, 
one of which is fully substituted. 
 
Scheme 3. Synthesis of Spiro Indoxyl Derivative 10 
 
 
  In summary, we have developed an efficient method for 
the  catalytic  enantioselective  synthesis  of  4-substituted 
tetrahydro-γ-carbolines  using  a  readily  available  chiral 
thiourea  and  BzOH.  Optically  pure  products  (98%  to 
>99%  ee)  were  obtained  through  a  one-pot  protocol  of 
condensation,  enantioselective  cyclization,  and  Boc-
protection,  followed  by  trituration  or  recrystallization. 
The application of this methodology to new alkaloid-like 
scaffolds  such  as  10  is  the  subject  of  ongoing 
investigation.  
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